| 000 | 01429 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513124940.0 | ||
| 264 | 0 | _c19971009 | |
| 008 | 199710s 0 0 fre d | ||
| 022 | _a0181-5512 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJeddi, A | |
| 245 | 0 | 0 |
_a[Value of clindamycin in the treatment of ocular toxoplasmosis]. _h[electronic resource] |
| 260 |
_bJournal francais d'ophtalmologie _c1997 |
||
| 300 |
_a418-22 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; English Abstract; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aChorioretinitis _xdrug therapy |
| 650 | 0 | 4 |
_aClindamycin _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPyrimethamine _xtherapeutic use |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aSulfadiazine _xtherapeutic use |
| 650 | 0 | 4 |
_aToxoplasmosis, Ocular _xcomplications |
| 700 | 1 | _aAzaiez, A | |
| 700 | 1 | _aBouguila, H | |
| 700 | 1 | _aKaoueche, M | |
| 700 | 1 | _aMalouche, S | |
| 700 | 1 | _aDaghfous, F | |
| 700 | 1 | _aAyed, S | |
| 773 | 0 |
_tJournal francais d'ophtalmologie _gvol. 20 _gno. 6 _gp. 418-22 |
|
| 999 |
_c9274617 _d9274617 |
||